How to do random allocation (randomization)
Jeehyoung Kim, Wonshik Shin, Jeehyoung Kim, Wonshik Shin
Abstract
Purpose: To explain the concept and procedure of random allocation as used in a randomized controlled study.
Methods: We explain the general concept of random allocation and demonstrate how to perform the procedure easily and how to report it in a paper.
Keywords: Block randomization; Random allocation; Simple randomization; Stratified randomization.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures






References
- Bhandari M, Richards RR, Sprague S, Schemitsch EH. The quality of reporting of randomized trials in the Journal of Bone and Joint Surgery from 1988 through 2000. J Bone Joint Surg Am. 2002;84(3):388–396.
- Montané E, Vallano A, Vidal X, Aguilera C, Laporte JR. Reporting randomised clinical trials of analgesics after traumatic or orthopaedic surgery is inadequate: a systematic review. BMC Clin Pharmacol. 2010;10:2.
Source: PubMed
Upcoming Clinical Trials
-
NCT07803653Not yet recruitingStage IVB Prostate Cancer AJCC v8 | Metastatic Castration-Resistant Prostate Adenocarcinoma
-
NCT07803666Not yet recruitingExercise | Blood Pressure | Nutrition Knowledge
-
NCT07803692Not yet recruiting
-
NCT07803705Not yet recruitingObesity | Overweight | Fatty Pancreas
-
NCT07803718Not yet recruitingPeripheral Artery Disease | Atherectomy in Diseased Lower Extremity Arteries
-
NCT07803731Not yet recruitingSacroiliac Joint Dysfunction
-
NCT07803744Not yet recruitingObesity | Diabetes Mellitus, Type 1 | Overweight
-
NCT07803757Not yet recruitingDental Caries | Cervical Caries
-
NCT07803770Not yet recruitingPancreatic Neoplasms | Radiomics | Pancreatic Ductal Adenocarcinoma (PDAC) | Endoscopic Ultrasound (EUS) | Artificial Intelligence (AI)
-
NCT07803783Not yet recruitingMetastatic Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma (PDAC)
-
NCT07803796Not yet recruitingBody Dysmorhpic Disorder | Positive Psychology
-
NCT07803809RecruitingType 2 Diabetes Mellitus (T2DM) | MASH - Metabolic Dysfunction-Associated Steatohepatitis | Overweight , Obesity